Dose-intensified rechallenge with temozolomide: one week on/one week off versus 3 weeks on/one week off in patients with progressive or recurrent glioblastoma - Weller, M; Tabatabai, G; Reifenberger, G
J Clin Oncol 2010;28(15_suppl)